Skip to main content
Caplight Logo









ARMR Sciences Inc.

ARMR Sciences Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps://armrsciences.com/

Last Round

Strategic

Jun 23, 2026

Momentum

Top 10%

of companies Caplight tracks

Company Overview

ARMR Sciences Inc. is a biotechnology company developing preventive immunotherapies and biodefense countermeasures to protect against synthetic drug threats such as fentanyl.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

fentanyl vaccinebiodefensemedical countermeasuressubstance use disorderopioid overdose preventionaddiction medicineclinical trialsbiotechnologyprophylactic vaccinebiosecuritydrug addiction vaccineoverdose antidoteB2Ggovernment contracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ARMR Sciences Inc. Comparables

Compare ARMR Sciences Inc. with similar companies based on industry and business-model similarity.

ARMR Sciences Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cessation Therapeutics
84%
Eolas Therapeutics, Inc.
73%
Baseline Therapeutics
66%

ARMR Sciences Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJun 23, 2026
Series A ExtensionAug 5, 2025

Key People

Founding team and executive leadership

Collin Gage

Co-founder & Chief Executive Officer

Founding Team

Jeff Neidhardt

Chief Financial Officer

Executive Team

ARMR Sciences Inc. Investors

Notable investors and investment history

ARMR Sciences Inc. investors
InvestorRounds
Zola GlobalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 12, 2026

    Monthly visitors increased 71% MoM.

  • Jul 26, 2026

    Monthly visitors increased 44% MoM.

ARMR Sciences Inc. Filings

Explore SEC and related filing metadata, where available.

ARMR Sciences Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ARMR Sciences Inc.'s valuation, stock price, and market status.

Is ARMR Sciences Inc. a public or private company?

ARMR Sciences Inc. is a private company.

What is the current stock price of ARMR Sciences Inc.?

ARMR Sciences Inc. is a private company, so its shares have no public market price. Caplight tracks ARMR Sciences Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ARMR Sciences Inc. worth (valuation)?

Valuation information for ARMR Sciences Inc. is not publicly available.

Can I buy ARMR Sciences Inc. stock?

ARMR Sciences Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ARMR Sciences Inc.'s last funding round?

ARMR Sciences Inc.'s most recent funding round was Strategic on June 23, 2026.

Who are the main investors in ARMR Sciences Inc.?

Key investors in ARMR Sciences Inc. include Zola Global.

Will ARMR Sciences Inc. IPO soon?

No public IPO plans have been announced for ARMR Sciences Inc..

How can I track ARMR Sciences Inc. secondary market activity?

Caplight tracks bids, offers, and trades in ARMR Sciences Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range16
Year Founded2023
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?